Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Current Size And Growth Outlook For The Hereditary Testing Market?

Over the past few years, the hereditary testing market has witnessed significant expansion. Projections suggest escalating from a value of $6.05 billion in 2024 to $6.62 billion in 2025, marking a compound annual growth rate (CAGR) of 9.3%. Factors contributing to this historic period of growth include elevated parental age, growing use for assessing cancer risk, the increasing demand for early detection and prevention, a higher incidence of rare and chronic diseases, improved access to genetic counseling services, and rising utilization of hereditary testing in the sphere of reproductive health.

Projected to experience substantial expansion in the forthcoming years, the hereditary testing market is anticipated to attain a value of $9.35 billion by 2029, flourishing at a compound annual growth rate (CAGR) of 9.0%. Factors contributing to the growth during this forecast period include the growing alliances between public and private genomic entities, increased demand for non-invasive prenatal testing (NIPT), a surge in the availability of genetic testing panels and kits, more extensive utilization in nationwide screening programs, and an increasing focus on preemptive and precision public health initiatives. The forthcoming period foresees significant trends involving advancements in next-generation sequencing (NGS), technological innovation in non-invasive prenatal testing (NIPT), progress in bioinformatics platforms, improvements in point-of-care genetic testing apparatus, and advances in multi-gene panel testing.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25782&type=smp

What Core Drivers Are Expected To Influence The Hereditary Testing Market?

The escalating incidence of genetic disorders is projected to stimulate the expansion of the hereditary testing market in the future. Genetic disorders are medical complications arising from abnormalities or mutations in a person’s deoxyribonucleic acid, either inherited from one or both parents or developed spontaneously. The surge in genetic disorders is partly attributable to rising parental age, which amplifies the probability of genetic mutations being transferred to their children. Hereditary testing aids patients with genetic disorders by facilitating timely diagnosis, guiding customized treatment, and assisting in family planning decisions via the detection of inherited mutations. For example, the Cystic Fibrosis Trust, a UK-based charity, reported in October 2024, that the number of recorded patients with cystic fibrosis increased to 11,318 in 2023, a rise from 11,148 in 2022. Thus, the growing incidence of genetic disorders is bolstering the expansion of the hereditary testing market.

Which Segmentation Categories Are Highlighted In The Hereditary Testing Market Analysis?

The hereditary testing market covered in this report is segmented –

1) By Test Type: Predictive Testing, Carrier Testing, Prenatal Testing, Newborn Screening, Diagnostic Testing, Other Test Types

2) By Sample Type: Blood Samples, Saliva Samples, Tissue Samples, Buccal Swabs, Urine Samples

3) By Technology Used: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Sanger Sequencing, Microarray Technology, Whole Genome Sequencing (WGS)

4) By Application: Oncology, Cardiovascular Diseases, Neurological Disorders, Metabolic Disorders, Other Applications

5) By End User: Hospitals, Diagnostic Laboratories, Research Institutes, Pharmaceutical Companies, Patients And Consumers

Subsegments:

1) By Predictive Testing: Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Gene Mutation Testing, Lynch Syndrome Testing, Familial Hypercholesterolemia Testing, Huntington’s Disease Testing, Cardiomyopathy Genetic Testing

2) By Carrier Testing: Cystic Fibrosis Carrier Screening, Tay-Sachs Carrier Screening, Spinal Muscular Atrophy (SMA) Carrier Screening, Thalassemia Carrier Screening, Sickle Cell Carrier Testing

3) By Prenatal Testing: Non-Invasive Prenatal Testing (NIPT), Chorionic Villus Sampling (CVS), Amniocentesis, Expanded Carrier Screening (Prenatal Context), Cell-Free Fetal Deoxyribonucleic Acid Testing

4) By Newborn Screening: Phenylketonuria (PKU) Screening, Congenital Hypothyroidism Screening, Cystic Fibrosis Screening, Sickle Cell Disease Screening, Hearing Loss and Metabolic Disorder Panels

5) By Diagnostic Testing: Rare Disease Genetic Testing, Inherited Cancer Diagnostic Testing, Cardiogenetic Diagnostic Panels, Neurogenetic Disorder Testing, Monogenic Disease Panels

6) By Other Test Types: Pharmacogenomics Testing, Preimplantation Genetic Diagnosis (PGD), Whole Exome Sequencing (WES), Whole Genome Sequencing (WGS), Mitochondrial Deoxyribonucleic Acid Testing

Which Market Trends Are Expected To Define The Future Of The Hereditary Testing Market?

Key players in the hereditary testing market are emphasizing technological innovation in genetic test kits to boost precision, minimize processing times, and increase the ability to detect a wider spectrum of genetic mutations. Genetic test kits are diagnostic devices that examine a person’s deoxyribonucleic acid (DNA) to detect genetic mutations or variations related to inherited illnesses or disease risk. For example, in July 2023, Devyser Diagnostics AB, a biotechnology company based in Sweden that specializes in making and selling DNA diagnostic kits for inherited disease testing, introduced two new targeted next-generation sequencing kits, Devyser LynchFAP and Devyser BRCA PALB2. Devyser LynchFAP uniquely facilitates a comprehensive analysis of PMS2 (surmounting issues posed by its pseudogene PMS2CL) in addition to nine other important genes associated with hereditary colorectal cancer syndromes. Devyser BRCA PALB2 is a seamless single-tube solution that screens for BRCA1, BRCA2, and PALB2 mutations in both blood and tumor specimens. It is crafted to simplify lab workflows and provides effective, user-friendly sequencing and specialized software to aid reliable detection of hereditary cancer risks.

Who Are The Dominant Players In The Hereditary Testing Market Today?

Major companies operating in the hereditary testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., CooperSurgical Inc., QIAGEN N.V, Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc, Invitae Corporation, GeneDx LLC, Twist Bioscience Corporation, Color Health Inc., MedGenome Inc, SOPHiA GENETICS SA, Gene By Gene Ltd., Dante Labs Inc., 23mofang Co. Ltd.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/hereditary-testing-global-market-report

Which Regional Markets Are Emerging As Key Hubs For The Hereditary Testing Market?

North America was the largest region in the hereditary testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hereditary testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=25782&type=smp

Browse Through More Reports Similar to the Global Hereditary Testing Market 2025, By The Business Research Company

Prenatal And Newborn Genetic Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/prenatal-and-newborn-genetic-testing-global-market-report

Genetic Testing Services Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/genetic-testing-services-global-market-report

Genetic Toxicology Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/genetic-toxicology-testing-global-market-report

About The Business Research Company:

With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model